Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Colloids Surf B Biointerfaces ; 212: 112363, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35123194

RESUMO

Given their large surface area and versatile chemical reactivity, single-walled carbon nanotubes (SWCNTs) are regarded as the basis of new pharmacological complexes. In this study, SWCNTs are chemically functionalized with fluorescein, folic acid, and capecitabine, a drug that is commonly used against colorectal cancer. These functionalized SWCNTs are dispersed in water by taking advantage of their synergistic interaction with type-II nanocrystalline cellulose (II-NCC), and the resulting colloidal system is tested in vitro on both normal (differentiated) and cancerous (proliferative) human colon cells (Caco-2). The functionalized SWCNT/II-NCC hybrids show a higher activity than the reference (capecitabine) against the Caco-2 cancer cell line. However, this effect appears to be intrinsically associated with the SWCNT/II-NCC complex, particularly boosted by fluorescein, as the presence of capecitabine is not required. In addition, confocal microscopy fluorescence imaging using cell cultures highlights the enormous potential of this nanohybrid platform for colon cancer theranostics.


Assuntos
Neoplasias do Colo , Nanotubos de Carbono , Células CACO-2 , Celulose , Neoplasias do Colo/tratamento farmacológico , Humanos , Nanotubos de Carbono/química
2.
Microb Ecol ; 72(3): 730-9, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27488594

RESUMO

Listeria monocytogenes is a Gram-positive bacterium that can cause a serious infection. Intestinal microorganisms have been demonstrated to contribute to intestinal physiology not only through immunological responses but also by modulating the intestinal serotonergic system. Serotonin (5-HT) is a neuromodulator that is synthesized in the intestinal epithelium and regulates the whole intestinal physiology. The serotonin transporter (SERT), located in enterocytes, controls intestinal 5-HT availability and therefore serotonin's effects. Infections caused by L. monocytogenes are well described as being due to the invasion of intestinal epithelial cells; however, the effect of L. monocytogenes on the intestinal epithelium remains unknown. The main aim of this work, therefore, was to study the effect of L. monocytogenes on SERT. Caco2/TC7 cell line was used as an enterocyte-like in vitro model, and SERT functional and molecular expression assays were performed. Our results demonstrate that living L. monocytogenes inhibits serotonin uptake by reducing SERT expression at the brush border membrane. However, neither inactivated L. monocytogenes nor soluble metabolites were able to affect SERT. The results also demonstrate that L. monocytogenes yields TLR2 and TLR10 transcriptional changes in intestinal epithelial cells and suggest that TLR10 is potentially involved in the inhibitory effect observed on SERT. Therefore, L. monocytogenes, through TLR10-mediated SERT inhibition, may induce increased intestinal serotonin availability and potentially contributing to intestinal physiological changes and the initiation of the inflammatory response.


Assuntos
Células CACO-2/efeitos dos fármacos , Intestinos/microbiologia , Listeria monocytogenes/metabolismo , Listeria monocytogenes/patogenicidade , Inibidores Seletivos de Recaptação de Serotonina/antagonistas & inibidores , Proteínas da Membrana Plasmática de Transporte de Serotonina/efeitos dos fármacos , Técnicas de Cultura de Células , Células Epiteliais/metabolismo , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Listeria monocytogenes/efeitos dos fármacos , Listeria monocytogenes/crescimento & desenvolvimento , Listeriose , Técnicas Microbiológicas , Fator 88 de Diferenciação Mieloide , Serotonina/biossíntese , Serotonina/metabolismo , Serotonina/farmacologia , Proteínas da Membrana Plasmática de Transporte de Serotonina/biossíntese , Receptor 10 Toll-Like/antagonistas & inibidores , Receptor 10 Toll-Like/metabolismo , Receptor 2 Toll-Like/metabolismo
3.
Biochem Pharmacol ; 78(9): 1198-204, 2009 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-19539610

RESUMO

Serotonin plays a critical role in the regulation of intestinal physiology. The serotonin transporter (SERT) expressed in the intestinal epithelium determines 5-HT availability and activity. The serotoninergic system and SERT activity have been described as being altered in chronic intestinal pathologies such as inflammatory diseases. Adenosine has also been shown to be involved in a variety of intestinal functions and to play a central role in the regulation of inflammatory responses of injured tissue. Since the modulation of SERT by adenosine in the intestine remains unknown, the aim of the present work was to study the effect of adenosine on SERT activity and expression and to determine the molecular mechanism involved. The study has been carried out using human enterocyte-like Caco-2 cells which endogenously express SERT. The results show that adenosine diminishes SERT activity in both the apical and basal membranes by acting in the intrinsic molecule with no alteration of either SERT mRNA or protein levels. The effect of adenosine appears to be mediated by A(2) receptors and activation of the cAMP/PKA signalling pathway. Moreover, the adenosine effect did not seem to involve the activation of AMP activated protein kinase. Adenosine effects are reached at high concentrations, which suggests that adenosine modulation of SERT may be significant under conditions of inflammation and tissue injury.


Assuntos
Adenosina/farmacologia , Mucosa Intestinal/efeitos dos fármacos , Proteínas da Membrana Plasmática de Transporte de Serotonina/efeitos dos fármacos , Sequência de Bases , Western Blotting , Células CACO-2 , Primers do DNA , Humanos , Mucosa Intestinal/citologia , Mucosa Intestinal/metabolismo , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Transdução de Sinais
4.
J Physiol Pharmacol ; 60(1): 157-64, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19439818

RESUMO

Serotonin (5-HT) receptors are expressed in the gastrointestinal tract and play an important role in gastrointestinal activity regulation. 5-HT binding to receptors depends on 5-HT availability, which is, in part, modulated by the 5-HT transporter (SERT) expressed in enterocytes. This work concerns the expression of 5-HT(1A) and 5-HT(7) receptors (5-HTR(1A) and 5-HTR(7)) in the human enterocyte-like Caco-2 cell line and their role in SERT activity modulation. The results demonstrate the mRNA and protein expression of 5-HTR(1A) and 5-HTR(7) in these cells. In addition, both receptors are shown to modulate SERT activity; 5-HTR(1A) activation increased 5-HT uptake and 5-HTR(7) activation inhibited it. In both cases, SERT modulation might involve a cAMP/PKA pathway. Effects on SERT disappeared after long-term activation of 5-HTR(1A) and 5-HTR(7), indicating their desensitization. However, in both cases, the desensitization did not show itself to be mediated by a reduction of the amount of receptors in the membrane.


Assuntos
Receptor 5-HT1A de Serotonina/metabolismo , Receptores de Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Células CACO-2 , AMP Cíclico/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Expressão Gênica , Humanos , RNA Mensageiro/metabolismo , Receptor 5-HT1A de Serotonina/genética , Receptores de Serotonina/genética , Serotonina/metabolismo
5.
J Physiol Pharmacol ; 57(1): 119-30, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16601320

RESUMO

The serotonin transporter (SERT) has shown itself to be an effective pharmacological target in the treatment of mood disorders and some kinds of gastrointestinal syndromes. Most of the molecular studies of SERT in humans have been carried out using heterologous models. In this work, we have investigated the human enterocyte-like Caco-2 cell line as a potential "in vitro" model to study the human SERT. The results show that these cells express a SERT mRNA identical to the human brain SERT, and a 70 kDa protein immunodetected using a specific antibody. The SERT activity levels in Caco-2 cells increased in correlation with the onset and maintenance of the morphological and functional differentiation of the cells. Caco-2 SERT was also shown to be a high affinity (Kt=0.216 microM) saturable, Na(+) -dependent transporter that was inhibited by fluoxetine (IC(50)=17.6 nM). In addition, SERT activity was inhibited by the intracellular modulators protein kinase C and cAMP, either after short or long-term treatment. In short, the expression and molecular characteristics of the human SERT in Caco-2 cells indicate that this cell line may be an ideal tool to study in vitro the physiology and pharmacology of human SERT.


Assuntos
Células CACO-2/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , AMP Cíclico/metabolismo , Expressão Gênica , Humanos , Cinética , Dados de Sequência Molecular , Proteína Quinase C/metabolismo , RNA Mensageiro/metabolismo , Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética
6.
Dig Dis Sci ; 47(6): 1316-22, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12064807

RESUMO

Tumor necrosis factor-alpha (TNF-alpha) has been proposed as an early proximal mediator of many metabolic and physiologic responses during septic shock. We have previously shown that direct addition to tissue (local effect) or intravenous administration (systemic effect) of lipopolysaccharide (LPS) reduces L-leucine absorption across rabbit jejunum. In the present study, we investigated whether the inhibitory effect of LPS on L-leucine intestinal absorption in rabbit is related to TNF-alpha. The results shown that the addition of TNF-alpha to tissue does not produce any effect on L-leucine uptake by the enterocyte. When TNF-alpha was inoculated by intravenous administration, a strong inhibition on the L-leucine uptake (about 40%), mediated by a secretagogue effect on water and Cl-ions was induced. We also found that the LPS intestinal effect induced by intravenous administration, was blocked by a TNF-alpha antagonist, indicating that TNF-alpha is a mediator of the LPS systemic effect on L-leucine intestinal uptake inhibition. The study of possible mediators involved in the TNF-alpha effect showed that nitric oxide and prostaglandins are implicated in the L-leucine intestinal uptake.


Assuntos
Absorção Intestinal/fisiologia , Leucina/metabolismo , Lipopolissacarídeos/farmacologia , Fator de Necrose Tumoral alfa/fisiologia , Animais , Enterócitos/metabolismo , Absorção Intestinal/efeitos dos fármacos , Masculino , Coelhos
7.
J Endotoxin Res ; 8(2): 127-33, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12028752

RESUMO

Lipopolysaccharide (LPS) is a known causative agent of sepsis. In previous studies, we have shown that it reduces L-leucine mediated transport across the rabbit jejunum by about 30%. In this study, the mechanism(s) of LPS inhibition on amino acid transport were analysed in detail. LPS did not inhibit L-leucine transport across brush border membrane vesicles, suggesting the need for an intracellular step. The inhibitory effect of LPS was not altered by the addition of protein kinase A (PKA) inhibitor (IP(20), 10(-7) M) or an analog of cAMP (DB-cAMP, 3 x 10(-4) M), indicating that the PKA signal transduction pathway was not involved in the LPS effect. However, the inhibitory effect of LPS was suppressed by trifluoroperazine (10(-7) M), a Ca(2+)/calmodulin inhibitor and staurosporine (10(-7) M), an protein kinase C (PKC) inhibitor. Likewise, LPS inhibition disappeared in media without calcium. These results suggest that LPS could inhibit the intestinal uptake of L-leucine across the small intestine in vitro by intracellular processes related to calcium, involving PKC and calmodulin protein.


Assuntos
Proteínas de Escherichia coli , Jejuno/metabolismo , Leucina/metabolismo , Lipopolissacarídeos/farmacologia , Aminoácidos/metabolismo , Animais , Toxinas Bacterianas/toxicidade , Transporte Biológico Ativo/efeitos dos fármacos , Cálcio/fisiologia , Sinalização do Cálcio/efeitos dos fármacos , AMP Cíclico/fisiologia , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Enterotoxinas/toxicidade , Inibidores Enzimáticos/farmacologia , Absorção Intestinal/efeitos dos fármacos , Jejuno/química , Jejuno/efeitos dos fármacos , Masculino , Microvilosidades/efeitos dos fármacos , Microvilosidades/metabolismo , Proteína Quinase C/metabolismo , Coelhos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , Água/metabolismo
8.
Dig Dis Sci ; 46(5): 1113-9, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11341657

RESUMO

In the present study, we have investigated whether the lipopolysaccharide (LPS) endotoxin from Escherichia coli is able to alter the jejunal transport of L-leucine when the tissue is exposed to endotoxin. The results have shown that the LPS at 3 x 10(-5) microg/ml decreases the uptake of L-leucine into the enterocyte, as well as the mucosal to serosal flux of L-leucine. The secretagogue effect of LPS on the gut did not affect the inhibitory effect of LPS on the intestinal absorption of the amino acid. The endotoxin did not modify amino acid diffusion across the intestinal epithelium. However, from the mediated transport, only the Na+-dependent transport system was affected by LPS with a diminution of the transporter affinity (the apparent Km was increased). In addition, we found a reduction of the Na+, K+-ATPase activity, which could explain the L-leucine Na+-dependent transport inhibition.


Assuntos
Endotoxinas/farmacologia , Escherichia coli , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Leucina/metabolismo , Lipopolissacarídeos/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Técnicas In Vitro , Absorção Intestinal/efeitos dos fármacos , Jejuno/efeitos dos fármacos , Jejuno/metabolismo , Masculino , Coelhos , ATPase Trocadora de Sódio-Potássio/metabolismo
9.
Life Sci ; 70(6): 615-28, 2001 Dec 28.
Artigo em Inglês | MEDLINE | ID: mdl-11833712

RESUMO

The objective of the present study was to determine the alterations in L-leucine intestinal uptake by intravenous administration of Lipopolysaccharide (LPS), which is a constituent of gram negative bacterial, causative agent of sepsis. The amino acid absorption in LPS treated rabbits was reduced compared to the control animals. The LPS effect on the amino acid uptake was due to an inhibition of the Na+-dependent system of transport, through both reduction of the apparent capacity transport (Vmax) and diminution of the Na+/K-ATPase activity. The results have also shown that the LPS decreases the mucosal to serosal transepithelial flux and the transport across brush border membrane vesicles of L-leucine. The study of possible intracellular mechanisms implicated in the LPS effect, showed that the second messengers calcium, protein kinase C and c-AMP did not play any role in this effect. However, the absence of ion chloride in the incubation medium removes the LPS inhibition and the intracellular tissue water was affected by the LPS treatment. Therefore, the inhibition in the L-leucine intestinal absorption, by intravenous administration of LPS, could be mainly produced by the secretagogue action of this endotoxin on the gut.


Assuntos
Escherichia coli/química , Absorção Intestinal/efeitos dos fármacos , Jejuno/efeitos dos fármacos , Leucina/metabolismo , Lipopolissacarídeos/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Cloretos/metabolismo , Relação Dose-Resposta a Droga , Injeções Intravenosas , Absorção Intestinal/fisiologia , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Íons , Jejuno/enzimologia , Jejuno/patologia , Lipopolissacarídeos/administração & dosagem , Masculino , Microvilosidades/efeitos dos fármacos , Microvilosidades/metabolismo , Técnicas de Cultura de Órgãos , Coelhos , ATPase Trocadora de Sódio-Potássio/metabolismo , Vesículas Transportadoras/efeitos dos fármacos , Vesículas Transportadoras/metabolismo
10.
Biol Reprod ; 63(2): 532-7, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10906061

RESUMO

The regulation of the phospholipase C (PLC) and the expression of inositol 1,4,5-trisphosphate receptors (IP(3)Rs) in terms of mRNA, proteins, and binding capacity were examined in the rat myometrium and endometrium at midgestation (Day 12) and at term (Day 21) comparatively to the estrogen-treated tissues (Day 0). In both uterine tissues, the production of inositol phosphates mediated by carbachol as well as by AlF(4)(-) was enhanced with advancing gestation. (3)[H]IP(3) binding sites in membranes also increased during pregnancy (Day 21 > Day 12 > Day 0). The mRNAs encoding for three isoforms of IP(3)R as well as their corresponding proteins, IP(3)R-1, IP(3)R-2, and IP(3)R-3 were coexpressed, albeit to different extents, in the myometrium and endometrium. The expression of IP(3)Rs increased with advancing gestation, except for IP(3)R-2 that increased only in the endometrium at term. Thus, the pregnancy-related upregulation of the PLC cascade coincided with an increase in the expression of IP(3)Rs. The difference noted between the two uterine tissues suggests that IP(3)Rs may have cell-specific functions.


Assuntos
Canais de Cálcio/genética , Endométrio/metabolismo , Expressão Gênica , Miométrio/metabolismo , Prenhez/metabolismo , Receptores Citoplasmáticos e Nucleares/genética , Animais , Northern Blotting , Canais de Cálcio/análise , Canais de Cálcio/metabolismo , Feminino , Idade Gestacional , Receptores de Inositol 1,4,5-Trifosfato , Fosfatos de Inositol/metabolismo , Gravidez , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Receptores Citoplasmáticos e Nucleares/análise , Receptores Citoplasmáticos e Nucleares/metabolismo , Trítio
11.
Can J Physiol Pharmacol ; 78(5): 359-66, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10841430

RESUMO

Serotonin has been shown to alter the intestinal transport of ions and intestinal motility. These effects may interfere with each other, modulating the whole physiology of the intestine. We have previously shown that serotonin also alters the transport of nutrients. Thus, the aims of the present work were to determine the possible interference between the secretagogue effect of serotonin and the mechanism by which serotonin inhibits the absorption of nutrients, and to study the effect of serotonin on the digestive activity of nutrients of the brush border membrane jejunum enterocyte in the rabbit. The results show that the secretagogue effect of serotonin neither affects the inhibitory effect of serotonin on the intestinal absorption of the nutrients, nor affects the activity of Na+/K+-ATPase. The activity of sucrase and aminopeptidase N was also not affected by serotonin in the rabbit jejunum. Finally, we also studied different parameters of the motility in the rabbit small intestine. Serotonin seemed to stimulate the motility of the rabbit small intestine by increasing integrated mechanical activity and tone of muscle fibers in duodenum, jejunum, and ileum. In conclusion, serotonin might alter or modulate the whole intestinal physiology.


Assuntos
Intestino Delgado/fisiologia , Serotonina/farmacologia , Aminoácidos/metabolismo , Animais , Água Corporal/metabolismo , Antígenos CD13/metabolismo , Metabolismo dos Carboidratos , Eletrofisiologia , Galactose/metabolismo , Motilidade Gastrointestinal/efeitos dos fármacos , Técnicas In Vitro , Absorção Intestinal/efeitos dos fármacos , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Leucina/metabolismo , Masculino , Microvilosidades/metabolismo , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Coelhos , Serotonina/sangue , ATPase Trocadora de Sódio-Potássio/metabolismo , Sacarase/metabolismo
12.
Biochem J ; 334 ( Pt 3): 633-40, 1998 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-9729472

RESUMO

The expression of the Na+/glucose cotransporter (SGLT1) in response to thyroid hormone [3,5,3'-tri-iodo-l-thyronine (T3)] was investigated in the enterocytic model cell line Caco-2/TC7. In differentiated cells, T3 treatment induces an average 10-fold increase in glucose consumption as well as a T3 dose-dependent increase in SGLT1 mRNA abundance. Only cells grown on glucose-containing media, but not on the non-metabolizable glucose analogue alpha-methylglucose (AMG), could respond to T3-treatment. The Vmax parameter of AMG transport was enhanced 6-fold by T3 treatment, whereas the protein abundance of SGLT1 was unchanged. The role of Na+ recycling in the T3-related activation of SGLT1 activity was suggested by both the large increase in Na+/K+ATPase protein abundance and the inhibition, down to control levels, of AMG uptake in ouabain-treated cells. Further investigations aimed at identifying the presence of a second cotransporter that could be expressed erroneously in the colon cancer cell line were unsuccessful: T3-treatment did not modify the sugar-specificity profile of AMG transport and did not induce the expression of SGLT2 as assessed by reverse transcription-PCR. Our results show that T3 can stimulate the SGLT1 cotransport activity in Caco-2 cells. Both transcriptional and translational levels of regulation are involved. Finally, glucose metabolism is required for SGLT1 expression, a result that contrasts with the in vivo situation and may be related to the fetal phenotype of the cells.


Assuntos
Glucose/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Proteínas de Transporte de Monossacarídeos/genética , Proteínas de Transporte de Monossacarídeos/metabolismo , Sódio/metabolismo , Tri-Iodotironina/farmacologia , Sequência de Bases , Células CACO-2 , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , DNA Complementar/genética , Expressão Gênica/efeitos dos fármacos , Humanos , Metilglucosídeos/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transportador 1 de Glucose-Sódio , Transportador 2 de Glucose-Sódio , ATPase Trocadora de Sódio-Potássio/metabolismo
13.
Biol Trace Elem Res ; 52(2): 133-42, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8773754

RESUMO

Cadmium compounds are widely spread in the environment. Animal exposure to cadmium compounds occurs mainly through foods or drinks contaminated by this metal. Cadmium has been shown to produce several negative effects on the gastrointestinal tract such as inhibition on sugars and amino acids absorption. The aim of the present work was to study the inhibitory characteristics of cadmium on L-threonine intestinal absorption in rabbits in order to understand about this malabsorption of nutrients. Our results show that L-threonine tissue accumulation as well as mucosal to serosal transepithelial fluxes are decreased in a dose-dependent manner in rabbit jejunum. Amino acid diffusion across the intestinal epithelium was not affected by cadmium. A noncompetitive mechanism and a partial reversion by dithioerythritol (thiol groups protector) is described for this inhibition.


Assuntos
Cádmio/farmacologia , Absorção Intestinal/efeitos dos fármacos , Treonina/farmacocinética , Animais , Transporte Biológico Ativo/efeitos dos fármacos , Interações Medicamentosas , Técnicas In Vitro , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Jejuno/efeitos dos fármacos , Jejuno/metabolismo , Masculino , Coelhos , Membrana Serosa/metabolismo
14.
Biol Trace Elem Res ; 51(2): 149-59, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8907018

RESUMO

The element Cd is considered to have no biological function and is highly toxic to humans and animals. Toxic effects of this metal upon cell membrane structure and function have been shown. On the other hand, Ca is an essential element in a wide variety of cellular activities. The present study was initiated to research whether the interaction between Ca and Cd could affect D-galactose absorption across the rabbit jejunum in vitro. In media with Ca2+, when CdCl2 was present at 0.5 or 1 mM, Cd was found to significantly reduce the sugar absorption. In Ca2+ -free media, where CaCl2, was omitted and replaced isotonically with choline chloride, the sugar transport was not modified by Cd, but when CaCl2 was replaced isotonically with MgCl2, the inhibition is observed. Verapamil at 10(-6)M (blocking mainly Ca2+ transport) did not modify the inhibitory effect of cadmium on D-galactose transport. When 10(-6)M of A 23187 (Ca2+ specific ionophore) was added in media with/without Ca2+; CdCl2 produced no change in D-galactose transport. These results suggest that Ca and Cd could have affinity for the same chemical groups of enterocyte membrane, which would be related with the intestinal absorption of D-galactose.


Assuntos
Cloreto de Cádmio/toxicidade , Bloqueadores dos Canais de Cálcio/farmacologia , Cálcio/metabolismo , Carcinógenos/toxicidade , Galactose/metabolismo , Absorção Intestinal/efeitos dos fármacos , Jejuno/efeitos dos fármacos , Análise de Variância , Animais , Cloreto de Cádmio/metabolismo , Calcimicina/farmacologia , Carcinógenos/metabolismo , Colina/metabolismo , Colina/toxicidade , Interações Medicamentosas , Epitélio/metabolismo , Técnicas In Vitro , Jejuno/metabolismo , Masculino , Nootrópicos/metabolismo , Nootrópicos/toxicidade , Coelhos , Estereoisomerismo , Verapamil/farmacologia , Água/metabolismo
15.
Biol Trace Elem Res ; 53(1-3): 213-23, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8862750

RESUMO

Zinc is a nutritionally essential trace element required for many biological functions to be successfully carried out. The aim of the present work was to study the influence of zinc on the intestinal absorption of L-threonine and on the aminopeptidase N activity in rabbit jejunum, after in vitro addition and/or oral administration of ZnCl2 in drinking water. Results obtained show that zinc decreases L-threonine absorption in the jejunal tissue. This effect would appear to be owing to an action mainly located in active amino acid transport, because zinc does not seem to modify the amino acid diffusion across the intestinal epithelium, of the mucosal border of the intestinal epithelium. Zinc has also been shown to inhibit the (Na(+)-K+)-ATPase activity of the enterocyte, which might explain the inhibition of the L-threonine Na(+)-dependent transport. Nevertheless, a direct action of the zinc on carriers of active transport cannot be rejected. However, zinc did not significantly modify the aminopeptidase N activity in rabbit jejunum.


Assuntos
Antígenos CD13/metabolismo , Jejuno/efeitos dos fármacos , Treonina/metabolismo , Oligoelementos/farmacologia , Zinco/farmacologia , Animais , Transporte Biológico , Técnicas In Vitro , Absorção Intestinal/efeitos dos fármacos , Jejuno/metabolismo , Coelhos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores
16.
Reprod Nutr Dev ; 35(3): 319-28, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7612170

RESUMO

Cadmium is a highly toxic metal that can damage a number of organs including the gastrointestinal tract. It has been shown that cadmium partially reduces L-threonine intestinal absorption probably by binding to membrane proteins which pertain to active transport systems or are functionally related to them. Calcium, however, is an essential element in a wide variety of cellular activities. The aim of the present work was to study whether the inhibitory cadmium effect on L-threonine absorption across rabbit jejunum could be modified by calcium. In media with Ca2+, cadmium significantly reduces the L-threonine absorption. In Ca(2+)-free media, where calcium chloride was omitted and replaced isotonically with choline chloride, this amino acid transport was not modified by cadmium but it was inhibited when calcium chloride was replaced isotonically with magnesium chloride. Verapamil (blocking mainly Ca2+ transport) did not modify the inhibitory effect of cadmium on L-threonine transport. When A 23187 (Ca2+ specific ionophore) was added in media with/without Ca2+, cadmium produced no change on L-threonine transport. These results suggest that calcium and cadmium could have an affinity for the same chemical groups on the enterocyte membrane. This property could affect the intestinal absorption of amino acids.


Assuntos
Cádmio/farmacologia , Cálcio/farmacologia , Absorção Intestinal/efeitos dos fármacos , Treonina/metabolismo , Animais , Transporte Biológico/efeitos dos fármacos , Calcimicina/farmacologia , Interações Medicamentosas , Ácido Egtázico/farmacologia , Masculino , Coelhos , Verapamil/farmacologia
17.
Res Vet Sci ; 57(1): 15-20, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7973088

RESUMO

The aim of the present work was to study whether zinc chloride added to the drinking water of rabbits affected the intestinal absorption of D-galactose and the activity of sucrase in the jejunum. The results showed that zinc decreased D-galactose absorption in the jejunal tissue. The effect appeared to be due mainly to an action on the active transport of the sugar by the mucosal border of the intestinal epithelium, because the zinc seemed not to affect its diffusion across the intestinal epithelium. Zinc was also shown to inhibit the (Na(+)-Ka+)-ATPase activity of the enterocyte, which might explain the inhibition of the Na(+)-dependent transport of D-galactose. Nevertheless, a possible direct action of the zinc ion on the Na(+)-dependent carrier cannot be discounted. Zinc did not alter the activity of sucrase in the jejunum of the rabbit.


Assuntos
Proteínas de Transporte de Cátions , Galactose/metabolismo , Absorção Intestinal/efeitos dos fármacos , Sacarase/efeitos dos fármacos , Zinco/farmacologia , Adenosina Trifosfatases/efeitos dos fármacos , Animais , Galactose/antagonistas & inibidores , Jejuno/efeitos dos fármacos , Masculino , Coelhos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores
18.
Reprod Nutr Dev ; 34(2): 115-23, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7910022

RESUMO

Cadmium has been recognized as an environmental contaminant. In oral cadmium intoxication, the immediate target organ is the gastrointestinal tract. The aim of the present work was to study the effect of cadmium on the intestinal absorption of L-threonine and on the aminopeptidase N activity in rabbit jejunum, after in vitro addition and/or oral administration of CdCl2 in drinking water. Results obtained show that cadmium decreases L-threonine absorption in the jejunal tissue. This effect seems to be due to an action mainly on active amino-acid transport at the mucosal border of the intestinal epithelium, because cadmium does not seem to modify the amino-acid diffusion across the intestinal epithelium. Cadmium also inhibits the (Na(+)-K+)-ATPase activity of the enterocyte, which might explain the inhibition of the Na(+)-dependent L-threonine transport. Nevertheless, a direct action of the cadmium ion on the carrier of active transport cannot be rejected. Cadmium modifies the aminopeptidase N activity when administered in drinking water for 4 d.


Assuntos
Aminopeptidases/metabolismo , Cádmio/farmacologia , Proteínas de Transporte de Cátions , Absorção Intestinal/efeitos dos fármacos , Treonina/metabolismo , Adenosina Trifosfatases/metabolismo , Animais , Antígenos CD13 , Jejuno/efeitos dos fármacos , Jejuno/enzimologia , Jejuno/metabolismo , Coelhos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores
19.
Biol Trace Elem Res ; 38(3): 217-26, 1993 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7504939

RESUMO

Cadmium compounds are found widely in our environment: for example, in food, water, soil, and ambient air. The most important exposure route of animals to cadmium in the general environment is via oral exposure. In oral cadmium intoxication, the immediate target organ is the gastrointestinal tract. The aim of the present work was to determine how cadmium acts on the intestinal absorption of sugars and on the sucrase activity through rabbit jejunum, after in vitro administration and/or oral administration of CdCl2 in drinking water. Results obtained show that cadmium decreases D-galactose accumulation in the jejunum tissue. This effect seems to be the results of an action mainly located on Na(+)-dependent sugar transport of the mucosal border of the intestinal epithelium, because cadmium seems not to modify the sugar diffusion across the intestinal epithelium. Cadmium has also been shown to inhibit the (Na(+)-K+)-ATPase activity of the enterocyte, which might explain the inhibition of the D-galactose Na(+)-dependent transport. Nevertheless, a direct action of the cadmium molecule on the Na(+)-dependent carrier cannot be discarded. Cadmium altered the sucrose activity when it was administered in the drinking water for 4 d.


Assuntos
Cádmio/farmacologia , Carboidratos/farmacocinética , Proteínas de Transporte de Cátions , Absorção Intestinal/efeitos dos fármacos , Intestino Delgado/metabolismo , Adenosina Trifosfatases/antagonistas & inibidores , Adenosina Trifosfatases/metabolismo , Animais , Água Corporal/metabolismo , Galactose/farmacocinética , Técnicas In Vitro , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/enzimologia , Mucosa Intestinal/metabolismo , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/enzimologia , Masculino , Coelhos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , ATPase Trocadora de Sódio-Potássio/metabolismo , Sacarase/metabolismo
20.
Res Vet Sci ; 54(2): 189-94, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8460258

RESUMO

Cadmium compounds are found widely in the environment: for example, in food, water, soil and ambient air. The most important exposure route of animals to cadmium in the general environment is oral. The aim of the present work was to determine how cadmium acts on the intestinal absorption of sugars by rabbits. Results obtained show that cadmium decreases both D-galactose accumulation in the jejunum tissue, and mucosal to serosal transepithelial fluxes of this sugar, in a dose-dependent way. Furthermore, cadmium seems not to modify the sugar diffusion across the intestinal epithelium. This inhibitory mechanism is non-competitive and it is partly reversed with dithioerythritol (thiol groups protector). Therefore, these results suggest that cadmium decreases carrier-mediated intestinal absorption of sugar in rabbits.


Assuntos
Cádmio/farmacologia , Galactose/metabolismo , Jejuno/metabolismo , Animais , Transporte Biológico , Água Corporal/metabolismo , Cádmio/administração & dosagem , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Masculino , Coelhos , Sódio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA